Market Tracker

05/24 5:16pm ET

Valeant Pharmaceuticals International Inc (NYSE:VRX)

26.11
Delayed Data
As of 4:00pm ET
 -0.10 / -0.38%
Today’s Change
23.55
Today|||52-Week Range
263.81
-74.31%
Year-to-Date
Billionaire Battleground: Valeant Pharmaceuticals Shares Are in Wall Street's Crossha...
4:24pm / MotleyFool.com - Paid Partner Content
Here's a Reason Why Valeant (VRX) Stock Is Down Today
May 23 / TheStreet.com - Paid Partner Content
One Reason Valeant (VRX) Stock is Down Today
11:01am / TheStreet.com - Paid Partner Content
Valeant, Apple and Starbucks: Doug Kass' Views
May 23 / TheStreet.com - Paid Partner Content
Valeant Pharmaceuticals: New Documents Shed Light on the Philidor Fiasco
8:25am / MotleyFool.com - Paid Partner Content
Valeant Pharmaceuticals International (VRX) Showing Signs Of A Dead Cat Bounce Today
May 20 / TheStreet.com - Paid Partner Content
Allergan to do Smaller Deals and Boost Credit Rating
May 23 / TheStreet.com - Paid Partner Content
Valeant Receives Default Notice, Accelerating Reporting Deadlines
May 20 / TheStreet.com - Paid Partner Content
Valeant to Evaluate Sales of Noncore Assets
May 23 / TheStreet.com - Paid Partner Content
Doug's Morning Musings
May 20 / TheStreet.com - Paid Partner Content

Today’s Trading

Previous close26.21
Today’s open26.34
Day’s range25.24 - 26.52
Volume22,356,372
Average volume (3 months)26,005,199
Market cap$8.9B
Dividend yield--
Data as of 4:00pm ET, 05/24/2016

Growth & Valuation

Earnings growth (last year)-131.25%
Earnings growth (this year)-15.97%
Earnings growth (next 5 years)+9.00%
Revenue growth (last year)+26.42%
P/E ratioNM
Price/Sales3.32
Price/Book1.52

Competitors

 Today’s
change
Today’s
% change
JAZZJazz Pharmaceuticals...+3.44+2.32%
MDVNMedivation Inc+1.16+1.91%
IDXXIDEXX Laboratories I...+2.10+2.38%
RDYDr.Reddy's Laborator...-0.06-0.13%
Data as of 4:02pm ET, 05/24/2016

Financials

Next reporting dateJune 10, 2016
EPS forecast (this quarter)$1.36
Annual revenue (last year)$10.4B
Annual profit (last year)-$291.7M
Net profit margin-2.79%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Joseph C. Papa
Chief Financial Officer, Director &
Executive VP
Robert L. Rosiello
Corporate headquarters
Laval, Quă©bec

Forecasts